Skip to content
Peptigraph home

SLU-PP-332 Side Effects: What Studies and Users Report

What FDA labels and clinical studies report for SLU-PP-332, how strong that evidence is, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureERR agonist (not a peptide)Updated

Side effects reported in studies

No side effects were reported in the study abstracts we summarised for SLU-PP-332 (PubMed search, 2 Oct 2026). Absence of reports is not evidence of safety: small and animal studies often do not measure or report harms.

What is not known

  • How common each effect is at the doses people use outside of studies.
  • Effects that take longer to appear than the length of the published studies.
  • How SLU-PP-332 interacts with other medicines and supplements.
  • Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.

When to get medical help

Get urgent care for: trouble breathing, swelling of the face or throat, a widespread rash, severe or lasting stomach pain, fainting, or an injection site that becomes hot, red and spreading.

This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.

Common questions

What are the side effects of SLU-PP-332?

No side effects were reported in the study abstracts we summarised for SLU-PP-332 (PubMed search, 2 Oct 2026). That is not evidence it is safe: small and animal studies often do not report harms.

Is SLU-PP-332 safe?

SLU-PP-332 has an FDA-approved label that lists its known risks. That label covers the approved product used as prescribed, not compounded or research-chemical versions.

More on SLU-PP-332

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Half-lifeWhat is measured, by route, and what is not.For weight lossWhat research says about SLU-PP-332 for weight loss.

Sources

  1. 1PubMed search: "SLU-PP-332"[tiab] (10 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: SLU-PP-332[tiab] OR SLU-PP-915[tiab] OR "ERR agonist"[tiab] AND exercise mimetic[tiab] (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.